Propofol Injectable Emulsion Vials Recalled for Particulate Matter Contamination
Pfizer is recalling 54,000 vials of Propofol Injectable Emulsion (Lot DX9067) due to presence of particulate matter identified as a beetle. No illnesses or injuries have been reported.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA classified this recall as Class I, which requires a minimum severity score of 4. Although no illnesses or injuries have been reported, contamination of an injectable anesthetic with confirmed foreign material (beetle) represents a serious potential risk of harm.
Plain-English summary
Pfizer Inc. has issued a Class I recall of Propofol Injectable Emulsion (10 mg/mL) due to the presence of particulate matter identified as a beetle in certain vials. The recalled product consists of 54,000 vials in Lot DX9067, with an expiration date of May 1, 2023, distributed nationwide throughout the USA.
Propofol is an intravenous anesthetic administered in medical and surgical settings. Contamination by foreign material in an injectable product presents a risk if administered to patients.
No illnesses or injuries related to this contamination have been reported to date. Healthcare providers and facilities in possession of affected vials from Lot DX9067 should cease use immediately and contact Pfizer or the FDA.
The recalled product
- Product
- PROPOFOL (PROPOFOL)
- Brand
- PROPOFOL
- Manufacturer
- Pfizer Inc.
- Category
- Drug — Anesthetic Injectable
- Hazard
- particulate-matter
- beetle-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: DX9067
- Exp 5/1/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · PROPOFOL
- CriticalPropofol Injectable Emulsion Recalled for Particulate Matter Contamination
FDA (Drugs) · 2022-09-21
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin 500 mg Tablets Recalled for Impurity Above Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModerateFentanyl Citrate Sterile Injection Recalled for Subpotent Drug Content
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27